Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) FCF Margin (2020)

Historic FCF Margin for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to 8660.61%.

  • Design Therapeutics' FCF Margin changed N/A to 8660.61% in Q4 2020 from the same period last year, while for Sep 2021 it was 73309.09%, marking a year-over-year change of. This contributed to the annual value of 339.55% for FY2024, which is 1796600.0% up from last year.
  • Per Design Therapeutics' latest filing, its FCF Margin stood at 8660.61% for Q4 2020.
  • Design Therapeutics' FCF Margin's 5-year high stood at 1872.54% during Q1 2020, with a 5-year trough of 9295.0% in Q3 2020.